IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer

Patients with epidermal growth factor receptor (EGFR) mutation-positive lung cancer show a dramatic response to EGFR-tyrosine kinase inhibitors (TKIs). However, acquired drug resistance eventually develops. This study explored the novel mechanisms related to TKI resistance. To identify the genes ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shang-Gin, Chang, Tzu-Hua, Tsai, Meng-Feng, Liu, Yi-Nan, Hsu, Chia-Lang, Chang, Yih-Leong, Yu, Chong-Jen, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356910/
https://www.ncbi.nlm.nih.gov/pubmed/30609749
http://dx.doi.org/10.3390/cancers11010036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356910/
https://www.ncbi.nlm.nih.gov/pubmed/30609749
http://dx.doi.org/10.3390/cancers11010036

Ejemplares similares